Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report report published on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of CALA remained flat at $0.01 on Friday. The company had a trading volume of 1,039 shares, compared to its average volume of 6,274. The business has a 50-day moving average price of $0.01 and a 200 day moving average price of $0.02. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.